ACQUIRED POROKERATOSIS

ACQUIRED POROKERATOSIS was reported 29 times

ACQUIRED POROKERATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETOPOSIDE PHOSPHATE 1 0.0006
1 BLEOMYCIN SULFATE 3 0.0003
2 ANASTROZOLE TABLETS 6 0.0003
3 ELBASVIR AND GRAZOPREVIR 1 0.0002
4 ANASTROZOLE 6 0.0002
5 RISEDRONATE SODIUM 3 0.0001
6 TEMOZOLOMIDE 2 0.0001
7 TOFACITINIB CITRATE 1 0.0001
8 ERGOCALCIFEROL 2 0.0001
9 TACROLIMUS OINTMENT 0.1% 8 0.0001
10 TACROLIMUS EXTENDED-RELEASE CAPSULES 8 0.0001
11 LEFLUNOMIDE 6 0.0001
12 TACROLIMUS 8 0.0001
13 BENRALIZUMAB 1 0.0000
14 PREDNISOLONE ORAL SOLUTION 7 0.0000
15 CISPLATIN 3 0.0000
16 ETOPOSIDE 2 0.0000
17 CYCLOSPORINE 3 0.0000
18 DEXLANSOPRAZOLE 1 0.0000
19 MYCOPHENOLATE MOFETIL 3 0.0000
20 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 3 0.0000
21 PEMBROLIZUMAB 2 0.0000
22 GABAPENTIN 6 0.0000
23 SIMVASTATIN 3 0.0000
24 CAPECITABINE 1 0.0000
25 METHOTREXATE SODIUM 5 0.0000
26 PACLITAXEL 1 0.0000
27 ASPIRIN 5 0.0000
28 ABATACEPT 1 0.0000
29 RITUXIMAB 1 0.0000
30 PREDNISONE 2 0.0000